GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (MEX:SNY N) » Definitions » Tax Provision

Sanofi (MEX:SNY N) Tax Provision : MXN-25,313 Mil (TTM As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sanofi Tax Provision?

Sanofi's tax provision for the six months ended in Dec. 2024 was MXN-16,182 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was MXN-25,313 Mil.

Sanofi Tax Provision Historical Data

The historical data trend for Sanofi's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Tax Provision Chart

Sanofi Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43,728.52 -36,113.91 -39,425.70 -18,825.31 -26,293.47

Sanofi Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29,202.70 -13,559.10 -5,312.55 -9,130.47 -16,182.28

Sanofi Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN-25,313 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (MEX:SNY N) » Definitions » Tax Provision
Comparable Companies
XPAR:VIRP LLY JNJ ABBV OCSE:NOVO B XSWX:ROG LSE:AZN MRK XSWX:NOVN AMGN PFE GILD BMY LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 XTER:BAYN BIIB
Traded in Other Exchanges
SNYNF:USA SNY:USA 1SAN:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW:Bulgaria SANO:Austria
Address
46, Avenue de la Great Army, Paris, FRA, 75017
Website
https://www.sanofi.com
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

No Headlines